Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft.

Zhou, H P; Yi, D H; Yu, S Q; Sun, G C; Cui, Q; Zhu, H L; Liu, J C; Zhang, J Z; Wu, T J

Zhou, H P; Yi, D H; Yu, S Q; Sun, G C; Cui, Q; Zhu, H L; Liu, J C; Zhang, J Z; Wu, T J.

Affiliation

Zhou HP; Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an City, Shannxi Province, China. zhp1977@fmmu.edu.cn

Transplant Proc ; 38(9): 3046-51, 2006 Nov.

Article in En | MEDLINE | ID: mdl-17112896

Subject(s)

Graft Survival/physiology; Heart Transplantation/physiology; Mesenchymal Stem Cell Transplantation; Animals; Cell Culture Techniques; DNA Primers; Heart Transplantation/immunology; Interferon-gamma/genetics; Interleukin-1/genetics; Interleukin-10/genetics; Lymphocyte Culture Test, Mixed; Mesenchymal Stem Cells/cytology; Rats; Rats, Inbred F344; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Homologous/immunology; Transplantation, Homologous/physiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Heart Transplantation / Mesenchymal Stem Cell Transplantation / Graft Survival Type of study: Prognostic_studies Limits: Animals Language: En Journal: Transplant Proc Year: 2006 Document type: Article Affiliation country: China Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links